Trademark: 97054846
Word
NEXTVIVO
Status Date
Tuesday, April 2, 2024
Filing Date
Thursday, September 30, 2021
Published for Opposition
Tuesday, August 9, 2022
5 Pharmaceutical preparations for use in immunology, autoimmune disease, oncology, and infectious disease; pharmaceutical preparations for antibody and cellular immunotherapies
42 Medical and scientific research in the fields of immunology, autoimmune disease, oncology, and infectious disease; research and development in the fields of antibody and cellular immunotherapies, and diagnostic tests; pharmaceutical research and development
The mark consists of two stylized intertwined circles to the left of a stylized "NEXTVIVO."
NEXT VIVO
Apr 3, 2024
Notice Of Approval Of Extension Request E-Mailed
Apr 2, 2024
Sou Extension 3 Granted
Apr 2, 2024
Sou Extension 3 Filed
Apr 2, 2024
Sou Teas Extension Received
Aug 11, 2023
Notice Of Approval Of Extension Request E-Mailed
Aug 9, 2023
Sou Extension 2 Granted
Aug 9, 2023
Sou Extension 2 Filed
Aug 9, 2023
Sou Teas Extension Received
Mar 25, 2023
Notice Of Approval Of Extension Request E-Mailed
Mar 23, 2023
Sou Extension 1 Granted
Mar 23, 2023
Sou Extension 1 Filed
Mar 23, 2023
Sou Teas Extension Received
Oct 4, 2022
Noa E-Mailed - Sou Required From Applicant
Aug 9, 2022
Official Gazette Publication Confirmation E-Mailed
Aug 9, 2022
Published For Opposition
Jul 20, 2022
Notification Of Notice Of Publication E-Mailed
Jun 30, 2022
Approved For Pub - Principal Register
Jun 30, 2022
Assigned To Examiner
Oct 29, 2021
Notice Of Design Search Code E-Mailed
Oct 28, 2021
New Application Office Supplied Data Entered
Oct 4, 2021
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
